E-Mail
Israel is the first country to report national data on the Pfizer-BioNTech vaccine, with observational analysis showing that two doses provide more than 95% protection against COVID-19 infection, hospitalisation, and death, including among the elderly, at a time when the B.1.1.7 variant was the dominant strain.
A single dose of the vaccine was associated with 58% protection against infection, 76% against hospitalisation, and 77% against death, emphasising the importance of fully vaccinating adults.
Challenges to controlling the pandemic remain, including uncertainty about the duration of immunity, the possible emergence of vaccine-resistant variants, and the need to increase vaccine coverage.
Two doses of the Pfizer-BioNTech COVID-19 vaccine provide more than 95% protection against infection, hospitalisation, severe illness, and death, including among the elderly, according to the first national-level observational assessment of its effectiveness in Israel, published i
Largest study so far of more than 17 million adults in England confirms that minority ethnic groups had a higher risk of testing positive, hospitalisation, admission to intensive care units (ICU), and death from COVID-19 compared with white groups, even after accounting for other factors known to increase risk like deprivation, occupation, household size and underlying health conditions.
Труд заключенных — прибыльное дело Сколько зарабатывает на колониях Россия?: Госэкономика: Экономика: Lenta ru lenta.ru - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lenta.ru Daily Mail and Mail on Sunday newspapers.
E-Mail Most detailed study to date including 345,000 people from 48 randomised clinical trials finds that blood pressure-lowering medication is effective in adults regardless of starting blood pressure level. Each 5mmHg reduction in systolic blood pressure lowered the relative risk of cardiovascular events by around 10%, even in people with normal blood pressure and those who had never had a heart attack or stroke. Authors call for global guidelines to be changed so that anyone with increased risk of cardiovascular disease is considered for blood-pressure lowering medication, irrespective of their blood pressure.
Blood pressure-lowering medication can prevent serious cardiovascular conditions such as strokes, heart failure and heart attacks even in adults with normal blood pressure, according to new research published in
FRS,
CST) as its new independent Co-Chair today.
The
CST is the government’s highest-level advisory body on science and technology, advising on issues that cut across the full range of the government’s responsibilities.
Members of the council are leading figures in the science and technology community, including representation from academia and key high-tech businesses. Presidents from the national academies and the Chief Executive of
UK Research and Innovation (
UKRI) participate as ex-officio members. Lord Browne will co-chair the council alongside the Government Chief Scientific Adviser, Sir Patrick Vallance.
The Government Chief Scientific Adviser, Sir Patrick Vallance, said:
Lord Browne brings with him a wealth of experience which will enable the council to continue to deliver high calibre advice on science and technology issues to the government. I look forward to working with him across a range of important issues.